Alunni-Fabbroni M, Manfioletti G, Manzini G, Xodo L E
Department of Biochemistry, Biophysics and Macromolecular Chemistry, University of Trieste, Italy.
Eur J Biochem. 1994 Dec 15;226(3):831-9. doi: 10.1111/j.1432-1033.1994.00831.x.
The effect of triplex-forming oligonucleotides (TFO) on the transcription activity of T7 RNA polymerase has been investigated by an in vitro assay. The TFOs, either containing only phosphate (PO2) or phosphate and phosphorothioate (POS) internucleotide linkages, were targeted to a 30-bp homopurine. homopyrimidine (R.Y) site cloned in plasmid Bluescript KS+ about four helical turns downstream from the T7 RNA promoter. Band-shift and ultraviolet absorption melting experiments showed that the designed pyrimidine PO2 and POS TFOs form stable triple-helical complexes with the R.Y target duplex (the delta GTFO values of triplex formation vary from -42 to -63 kJ/mol). The triple-helical complexes resulting from POS oligonucleotides were less stable (by 4-12 kJ/mol) than those obtained with PO2 analogues, the magnitude of destabilization being dependent on the number of POS groups present in the third strand. The designed TFOs were shown to efficiently repress bacteriophage T7 RNA polymerase transcription under different experimental conditions. The repression depended on pH, TFO concentration and temperature. When the TFO/template ratio was fixed to 100, a strong repressive effect was observed with normal and phosphorothioate pyrimidine TFOs, also under physiological conditions. In contrast, a purine-rich oligonucleotide containing 44% of guanine residues promoted only a weak transcription inhibition, even at a TFO/template ratio as high as 750. Both PO2- and POS-containing pyrimidine TFOs produced their strong repressive effect on T7 RNA polymerase transcription even when they were added to the reaction mixture simultaneously with the polymerase. A mechanism of transcription repression is discussed. The data reported in this paper are useful for designing oligonucleotides acting as artificial repressors in the antigene strategy and indicate that the R.Y target need not to be precisely confined to the promoter.
通过体外试验研究了三链形成寡核苷酸(TFO)对T7 RNA聚合酶转录活性的影响。这些TFO,要么只含有磷酸(PO2),要么含有磷酸和硫代磷酸(POS)核苷酸间连接,靶向于一个克隆在质粒pBluescript KS+中的30个碱基对的同型嘌呤-同型嘧啶(R.Y)位点,该位点位于T7 RNA启动子下游约四个螺旋圈处。凝胶迁移和紫外吸收熔解实验表明,设计的嘧啶PO2和POS TFO与R.Y靶双链体形成稳定的三链复合物(三链形成的ΔGTFO值在-42至-63 kJ/mol之间变化)。由POS寡核苷酸形成的三链复合物比用PO2类似物得到的复合物稳定性低(低4 - 12 kJ/mol),不稳定的程度取决于第三链中存在的POS基团的数量。结果表明,在不同实验条件下,设计的TFO能有效抑制噬菌体T7 RNA聚合酶的转录。这种抑制作用取决于pH、TFO浓度和温度。当TFO/模板比例固定为100时,在正常和硫代磷酸嘧啶TFO的情况下,即使在生理条件下也观察到了强烈的抑制作用。相反,一种含有44%鸟嘌呤残基的富含嘌呤的寡核苷酸,即使在TFO/模板比例高达750时,也仅促进微弱的转录抑制。含PO2和POS的嘧啶TFO即使在与聚合酶同时加入反应混合物时,也对T7 RNA聚合酶转录产生强烈的抑制作用。本文讨论了转录抑制的机制。本文报道的数据对于设计在反基因策略中作为人工阻遏物的寡核苷酸很有用,并表明R.Y靶不必精确地局限于启动子。